Kidney Protective Jacket
- Sponsor
- iiShield
- Study ID
- NCT07348458
- Status
- Recruiting
Conditions
- Kidney Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Kidney Protective Jacket — DEVICEThe KPJ™ is a novel thermal insulating protective jacket specifically designed to be applied to the kidney during transplant anastomoses, or the SWIT interval. It is applied prior to removing the kidney from cold storage, and remains on for the duration of anastomoses, after which it can be easily removed. The Kidney Protective Jacket (KPJ) was designed and developed in accordance with ISO 13485 and 21 CFR 820 design control requirements. Throughout the development process, relevant standards were applied, including those related to risk management (ISO 14971), usability engineering (IEC 62366), biocompatibility of materials (ISO 10993 series), and sterilisation validation (ISO 11137). Manufacturing is carried out by an ISO 13485-certified contract manufacturer, with processes including injection moulding of medical-grade silicone, assembly of the sterile barrier system (comprising a medical-grade plastic tray and Tyvek® seal), and final device packaging. Sterilisation is performed us
Study Details
This is a safety study designed to investigate the safety of utilizing the Kidney Protective Jacket (KPJ)™ during kidney transplantation. In general, we aim to use the device in all possible recipients, aiming to demonstrate its safety in the variable circumstances that may arise during kidney transplantation, e.g. single or multiple renal vessels, different-sized kidneys, and variable recipient size and weight.
Key Dates
- First listed
- Jan 16, 2026
- Start date
- Mar 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Kidney Protective JacketApplication of the KPJ to the renal transplant.
Primary Outcome Measure
Safety of the Kidney Protective Jacket [ Time Frame: Until 20 participants are recruited, baseline participant characteristics collected pre-operatively, intra-operative times noted, and incidence of serious adverse events at 30 days post procedure. ]
Central Contacts
- Amy Hort, MBBS (HONS), MS, FRACS+61432782850
- Phoebe Lau, BME (HONS), ME+61 421 931 429
Related Studies
- Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister DonorPHASE1/PHASE2 · Recruiting · Jeffrey Veale, MD · Los Angeles, California
- The KidneyCARE (Community Access to Research Equity) StudyRecruiting · Tufts Medical Center · Danville, Pennsylvania
- Assessment of Biomarker-Guided CNI Substitution In Kidney TransplantationPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Empagliflozin Treatment in Kidney Transplant RecipientsPHASE4 · Recruiting · VA Office of Research and Development · Hines, Illinois